Timely detection of carbapenemases by both phenotypic and genotypic methods is essential for developing strategies to control the spread of infections by carbapenem-resistant isolates and related morbidity and mortality. The aim of this study was to compare the performance of a commercial kit, the RAPIDEC® CARBA NP, and an in-house technique, the carbapenem inactivation method (CIM), against a panel of 136 carbapenemase-and noncarbapenemase-producing Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa isolates. RAPIDEC CARBA NP displayed 99% sensitivity and 100% specificity, whereas the sensitivity and specificity were 78% and 100% for the CIM test, respectively. A slight modification of the CIM test, a prolonged incubat...
Early identification of infections caused by carbapenemase-producing Enterobacterales (CPE) can help...
Performances of the Rapidec Carba NP test (bioMérieux) were evaluated for detection of all types of ...
The analytical performances of the RAPIDEC CARBA NP® (bioMérieux) and the β-CARBA® (Bio-Rad) tests w...
SANDALLI, Cemal/0000-0002-1298-3687; aktas, elif/0000-0003-3087-5425WOS: 000402567800007PubMed: 2757...
BACKGROUND:There is an urgent need for accurate and rapid diagnostic tests to identify carbapenemase...
Four screening assays aimed for rapid detection of carbapenemase production from Gram-negative bacte...
This study evaluated the performance of the Rapidec Carba NP test, which was introduced recently int...
A new phenotypic test, called the Carbapenem Inactivation Method (CIM), was developed to detect carb...
The objective of this study was the evaluation of the performance of two commercially available bioc...
Background: There is an urgent need for accurate and rapid diagnostic tests to identify carbapenemas...
Contains fulltext : 154105.PDF (publisher's version ) (Open Access)A new phenotypi...
Carbapenems are considered the last resort for the treatment of multidrug-resistant Enterobacteriace...
Rapidly progressing antibiotic resistance is a great challenge in therapy. In particular, the infect...
The global emergence of carbapenemases led to the need of developing new methods for their rapid det...
Carbapenems are considered the last resort for the treatment of multidrug-resistant Enterobacteriace...
Early identification of infections caused by carbapenemase-producing Enterobacterales (CPE) can help...
Performances of the Rapidec Carba NP test (bioMérieux) were evaluated for detection of all types of ...
The analytical performances of the RAPIDEC CARBA NP® (bioMérieux) and the β-CARBA® (Bio-Rad) tests w...
SANDALLI, Cemal/0000-0002-1298-3687; aktas, elif/0000-0003-3087-5425WOS: 000402567800007PubMed: 2757...
BACKGROUND:There is an urgent need for accurate and rapid diagnostic tests to identify carbapenemase...
Four screening assays aimed for rapid detection of carbapenemase production from Gram-negative bacte...
This study evaluated the performance of the Rapidec Carba NP test, which was introduced recently int...
A new phenotypic test, called the Carbapenem Inactivation Method (CIM), was developed to detect carb...
The objective of this study was the evaluation of the performance of two commercially available bioc...
Background: There is an urgent need for accurate and rapid diagnostic tests to identify carbapenemas...
Contains fulltext : 154105.PDF (publisher's version ) (Open Access)A new phenotypi...
Carbapenems are considered the last resort for the treatment of multidrug-resistant Enterobacteriace...
Rapidly progressing antibiotic resistance is a great challenge in therapy. In particular, the infect...
The global emergence of carbapenemases led to the need of developing new methods for their rapid det...
Carbapenems are considered the last resort for the treatment of multidrug-resistant Enterobacteriace...
Early identification of infections caused by carbapenemase-producing Enterobacterales (CPE) can help...
Performances of the Rapidec Carba NP test (bioMérieux) were evaluated for detection of all types of ...
The analytical performances of the RAPIDEC CARBA NP® (bioMérieux) and the β-CARBA® (Bio-Rad) tests w...